A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients With Chronic Hepatitis C Virus Genotype 1 Infection

BACKGROUND: Despite the introduction of new drug regimens with high effectiveness for the hepatitis C virus (HCV) patients, especially in HCV genotype 1, no cost-effectiveness study on the selection of the superior drug strategy in Iran has been conducted yet. OBJECTIVES: This study is aimed to asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Alavian, Seyed Moayed, Nikfar, Shekoufeh, Kebriaeezadeh, Abbas, Lotfi, Farhad, Sanati, Ehsan, Rezaei Hemami, Mohsen, Keshavarz, Khosro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295467/
https://www.ncbi.nlm.nih.gov/pubmed/28203449
http://dx.doi.org/10.5812/ircmj.37094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295467/
https://www.ncbi.nlm.nih.gov/pubmed/28203449
http://dx.doi.org/10.5812/ircmj.37094

Ejemplares similares